Authors :
Dr. Ravi Ranjan Singh; Kumari Pallavi; Dr. Sanjeev Ranjan
Volume/Issue :
Volume 8 - 2023, Issue 7 - July
Google Scholar :
https://bit.ly/3TmGbDi
Scribd :
https://tinyurl.com/5de3f2nf
DOI :
https://doi.org/10.5281/zenodo.8228861
Abstract :
Heart failure and metabolic syndrome do not have
well-established prognoses.It symbolizes a wide range of
cardiac diseases, all of which might advance at varying
rates. In terms of mortality and morbidity, this study
assesses the prognosis of heart failure in middle-aged
patients with metabolic syndrome.The patients
underwent standard heart failure treatment and
underwent 24-week rounds of monitoring. The distance
walked in 6 minutes and the NYHA class served as the
key endpoints, The distance covered in 6 minutes and
NYHA class served as the primary end criteria, with
LVEF, LVEDD, and QRS duration serving as the
supplementary end points. Conclusion: When compared
to patients without metabolic syndrome, those with
moderate to severe heart failure show less improvement
in their condition.
Keywords :
Prognosis of Heart Failure, Metabolic Syndrome, LVEDD, LVEF
Heart failure and metabolic syndrome do not have
well-established prognoses.It symbolizes a wide range of
cardiac diseases, all of which might advance at varying
rates. In terms of mortality and morbidity, this study
assesses the prognosis of heart failure in middle-aged
patients with metabolic syndrome.The patients
underwent standard heart failure treatment and
underwent 24-week rounds of monitoring. The distance
walked in 6 minutes and the NYHA class served as the
key endpoints, The distance covered in 6 minutes and
NYHA class served as the primary end criteria, with
LVEF, LVEDD, and QRS duration serving as the
supplementary end points. Conclusion: When compared
to patients without metabolic syndrome, those with
moderate to severe heart failure show less improvement
in their condition.
Keywords :
Prognosis of Heart Failure, Metabolic Syndrome, LVEDD, LVEF
